The acne treatment market would grow at a CAGR of 6.73% over the predicted time frame. The market is expected to increase in value from US$ 10.03 Bn in 2022 to US$ 16.9 Bn in 2030.
The on acne treatment Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2094
Report Scope of the Acne Treatment Market
| Report Coverage | Details |
| Market Size in 2022 | USD 10.3 Billion |
| Market Size by 2030 | USD 16.9 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.73% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Acne Type, Treatment, Drug Type, Gender, Route of Administration, End User, and Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Acne treatment Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Acne treatment market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Acne treatment market are included as given below:
Acne treatment Market Key Players
- PHYTOMER
- Skin Medica
- PCA
- Obaji
- Skin Better Science
- Colorescience
- Revision Skincare
- The BeautyHealth Company
- Sente
- Jan Marini Skin Research
- Glow Biotics LLC
- Perricone MD
Market Segments
By Product
- Therapeutic Treatment
- Antibiotics
- Retinoid Therapy
- Hormonal Drugs
- Anti-inflammatory Drugs
- Chemical Peels
- Devices
- Laser Devices
- Radio frequency Devices
By Acne Type
- Moderate
- Mild
- Moderate To Severe
By Treatment
- Medication
- Therapeutic Devices
By Drug Type
- Over the Counter (OTC)
- Prescription
By Gender
- Women
- Men
By Route of Administration
- Topical
- Oral
- Injectable
By End User
- Dermatology Clinics
- MedSpa
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global acne treatment market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the acne treatment market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Acne Treatment Market, By Product
7.1. Acne Treatment Market, by Product, 2022-2030
7.1.1. Therapeutic Treatment
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Devices
7.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Acne Treatment Market, By Acne Type
8.1. Acne Treatment Market, by Acne Type, 2022-2030
8.1.1. Moderate
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Mild
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Moderate To Severe
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Acne Treatment Market, By Treatment
9.1. Acne Treatment Market, by Treatment, 2022-2030
9.1.1. Medication
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Therapeutic Devices
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Acne Treatment Market, By Drug Type
10.1. Acne Treatment Market, by Drug Type, 2022-2030
10.1.1. Otc
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Prescription
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Acne Treatment Market, By Gender
11.1. Acne Treatment Market, by Gender, 2022-2030
11.1.1. Women
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Men
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Acne Treatment Market, By Route of Administration
12.1. Acne Treatment Market, by Route of Administration, 2022-2030
12.1.1. Topical
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Oral
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Injectable
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Acne Treatment Market, By End User
13.1. Acne Treatment Market, by End User, 2022-2030
13.1.1. Dermatology Clinics
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. MedSpa
13.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Acne Treatment Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.1.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.1.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.5. Market Revenue and Forecast, by Gender (2017-2030)
14.1.6. Market Revenue and Forecast, by End User (2017-2030)
14.1.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Gender (2017-2030)
14.1.8.6. Market Revenue and Forecast, by End User (2017-2030)
14.1.8.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.1.9.6. Market Revenue and Forecast, by End User (2017-2030)
14.1.9.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.2.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.2.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.8.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.8.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.9.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.9.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.10.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.10.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Gender (2017-2030)
14.2.11.6. Market Revenue and Forecast, by End User (2017-2030)
14.2.11.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.3.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.3.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.8.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.8.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.9.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.9.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.10.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.10.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Gender (2017-2030)
14.3.11.6. Market Revenue and Forecast, by End User (2017-2030)
14.3.11.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.4.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.4.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.8.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.8.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.9.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.9.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.10.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.10.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Gender (2017-2030)
14.4.11.6. Market Revenue and Forecast, by End User (2017-2030)
14.4.11.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.5.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.5.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.5. Market Revenue and Forecast, by Gender (2017-2030)
14.5.6. Market Revenue and Forecast, by End User (2017-2030)
14.5.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Gender (2017-2030)
14.5.8.6. Market Revenue and Forecast, by End User (2017-2030)
14.5.8.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Acne Type (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Treatment (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Drug Type (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Gender (2017-2030)
14.5.9.6. Market Revenue and Forecast, by End User (2017-2030)
14.5.9.7. Market Revenue and Forecast, by Route of Administration (2017-2030)
Chapter 15. Company Profiles
15.1. PHYTOMER
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Skin Medica
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. PCA
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Obaji
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. Skin Better Science
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Colorescience
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Revision Skincare
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. The BeautyHealth Company
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Sente
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Jan Marini Skin Research
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments